Michael Yang
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Michael J.
Yang is currently an Independent Director at Ionis Pharmaceuticals, Inc. and Pacira Biosciences, Inc., both starting in 2023.
Mr. Yang is also an Operating Partner at ARTIS Ventures Management LP.
Former roles include President, Chief Executive Officer & Director at ViaCyte, Inc. from 2021 to 2022; Director at Akcea Therapeutics, Inc. in 2020; President at Johnson & Johnson; Chief Commercial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. from 2017 to 2021; Vice President-Sales & Marketing at Ortho Biotech, Inc.; General Manager at Veridex LLC and Therakos LLC; President at Janssen Biotech, Inc.; and President-Immunology at Janssen Pharmaceuticals, Inc. from 2013 to 2017.
Education includes undergraduate studies at San Diego State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 7.940 ( 0 % ) | 607 410 $ | 31/05/2026 | |
PACIRA BIOSCIENCES, INC. 0,05 % | 10/06/2026 | 19.798 ( 0,05 % ) | 459 710 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Miembro de la Junta | 10/10/2023 |
| IONIS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 14/12/2023 |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Inversor de Capital Privado | - |
| Empresas | Cargo | Fin |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Director Ejecutivo | 01/10/2022 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 29/01/2021 |
| AKCEA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2020 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/03/2017 |
| JOHNSON & JOHNSON | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.